Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02585791 · ClinicalTrials.gov registry record · NA
Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02585791 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 30 participants.
The verdict
NCT02585791, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This aim will examine the acute and subacute exposures to electronic cigarette (EC) vapor generated from e-liquids without nicotine (NFEC) on life-time non smokers subjects by measuring changes in nasal ion transport and TGF-β levels. Nasal ion transport will be assessed by nasal potential difference (NPD). Tumor growth factor (TGF)-β levels (mRNA and protein by ELISA) will be assessed on nasal cells and lavages.
Interventions
- OTHER Propylene Glycol
- OTHER vegetable glycerin
- OTHER PG+VG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2019-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02585791
The ClinicalTrials.gov registry entry for NCT02585791 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Propylene Glycol is the first listed.
NCT02585791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02585791 about?
NCT02585791 is a clinical study titled "Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors". This aim will examine the acute and subacute exposures to electronic cigarette (EC) vapor generated from e-liquids without nicotine (NFEC) on life-time non smokers subjects by measuring changes in nasal ion transport and TGF-β levels. Nasal ion transport will be assessed by nasal potential differenc...
What is the current status of trial NCT02585791?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-22. Estimated completion is 2019-12-11.
What interventions are being tested in trial NCT02585791?
The interventions under investigation include: Propylene Glycol (OTHER), vegetable glycerin (OTHER), PG+VG (OTHER).
Who is sponsoring clinical trial NCT02585791?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.